Security · featured owners
LYEL Lyell Immunopharma Inc.
Health Care COM NEW Equity as of 2026 Q2 among managers we track
- 1 Owner
- Max 0.4%
- $5M
- 1 add
Who owns this now
Largest portfolio weights among featured holders · max 0.4% (James Silverman - Opaleye Management) · not free-float ownership
holders
sorted by value · long equity only · current book 2026 Q2 · open a manager for their book
| history | |||||
|---|---|---|---|---|---|
| James Silverman - Opaleye Management 2026 Q2 | 0.44% | Add +334.9% | 344,025 | $5M | history |
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $130,000 | $61,000 | $36,000 |
| Net income | -$234.63M | -$342.99M | -$274.45M |
| Net margin * | -180486.2% | -562285.2% | -762355.6% |
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $554.69M | $379.59M | $260.94M |
| Total non-current assets * | $195.34M | $111.26M | $79.11M |
| Total assets | $750.03M | $490.86M | $340.05M |
| Total current liabilities | $34.52M | $53.79M | $49.41M |
| Total non-current liabilities * | $60.56M | $54.25M | $42.44M |
| Total equity | $654.95M | $382.82M | $248.2M |
ownership over time
filing count by report period · click a bar for that quarter’s holders